Layer 1

Where next for MURs: redesign, refine or scrap?

Where next for MURs: redesign, refine or scrap?

MURs may have been introduced in 2005 to boost patients’ medicine compliance, but many pharmacists think that while they offer value to patients, there is room for improvement.

In 2016, academics concluded that MURs had no evidence for cost-effectiveness and there was significant variability in delivery. The review, led by Professor David Wright from the University of East Anglia, questioned their viability, against a backdrop of mounting pressures on pharmacists and lack of support for the service from GPs.

Professor Wright told C+D that he believed problems with MURs resulted from the speed of the service’s implementation, such as insufficient testing. Training and assessment was “variable” and many GPs were “dissatisfied” with the information they were receiving from pharmacists, he said.

In December 2016,

Want to read more ?

Login or Subscribe to Update Plus to continue reading our CPD content.

Job of the week

Pharmacy Manager - Bridlington
Competitive plus benefits (GPhC fees incl)